These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 14562943)
1. Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Meyer E; Jonas D; Schwab F; Rueden H; Gastmeier P; Daschner FD Infection; 2003 Aug; 31(4):208-15. PubMed ID: 14562943 [TBL] [Abstract][Full Text] [Related]
2. Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units. Meyer E; Schwab F; Jonas D; Rueden H; Gastmeier P; Daschner FD Intensive Care Med; 2004 Jun; 30(6):1089-96. PubMed ID: 15045167 [TBL] [Abstract][Full Text] [Related]
3. [SARI: surveillance of antibiotic use and bacterial resistance in German intensive care units. Correlation between antibiotic use and the emergence of resistance]. Meyer E; Jonas D; Schwab F; Gastmeier P; Rüden H; Daschner FD Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Apr; 47(4):345-51. PubMed ID: 15205777 [TBL] [Abstract][Full Text] [Related]
4. Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004. Meyer E; Schwab F; Gastmeier P; Rueden H; Daschner FD Infection; 2006 Dec; 34(6):303-9. PubMed ID: 17180583 [TBL] [Abstract][Full Text] [Related]
5. Methicillin-resistant Staphylococcus aureus in German intensive care units during 2000-2003: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units). Meyer E; Schwab F; Gastmeier P; Jonas D; Rueden H; Daschner FD Infect Control Hosp Epidemiol; 2006 Feb; 27(2):146-54. PubMed ID: 16465631 [TBL] [Abstract][Full Text] [Related]
6. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period. Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM; Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399 [TBL] [Abstract][Full Text] [Related]
7. Temporal changes in bacterial resistance in German intensive care units, 2001-2003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project. Meyer E; Schwab F; Jonas D; Ruden H; Gastmeier P; Daschner FD J Hosp Infect; 2005 Aug; 60(4):348-52. PubMed ID: 15923060 [TBL] [Abstract][Full Text] [Related]
8. [Quality assurance in intensive care medicine. SARI-surveillance on antibiotic use and bacterial resistance in intensive care units]. Meyer E; Schroeren-Boersch B; Schwab F; Jonas D; Rüden H; Gastmeier P; Daschner FD Anaesthesist; 2004 May; 53(5):427-33. PubMed ID: 15004690 [TBL] [Abstract][Full Text] [Related]
9. Surveillance of Antibiotic Use and Resistance in Intensive Care Units (SARI). Remschmidt C; Schneider S; Meyer E; Schroeren-Boersch B; Gastmeier P; Schwab F Dtsch Arztebl Int; 2017 Dec; 114(50):858-865. PubMed ID: 29271345 [TBL] [Abstract][Full Text] [Related]
10. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Meyer E; Schwab F; Schroeren-Boersch B; Gastmeier P Crit Care; 2010; 14(3):R113. PubMed ID: 20546564 [TBL] [Abstract][Full Text] [Related]
11. [Diversity in antibiotic use in intensive care units in Germany]. Meyer E; Schwab F; Schroeren-Boersch B; Rüden H; Gastmeier P Dtsch Med Wochenschr; 2008 Feb; 133(6):235-40. PubMed ID: 18236348 [TBL] [Abstract][Full Text] [Related]
12. Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units). Meyer E; Schwab F; Gastmeier P; Rueden H; Daschner FD; Jonas D J Hosp Infect; 2006 Nov; 64(3):238-43. PubMed ID: 16979794 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility testing and antibiotic consumption results from 16 hospitals in Viet Nam: The VINARES project 2012-2013. Vu TVD; Do TTN; Rydell U; Nilsson LE; Olson L; Larsson M; Hanberger H; Choisy M; Dao TT; van Doorn HR; Nguyen VK; Nguyen VT; Wertheim HFL; J Glob Antimicrob Resist; 2019 Sep; 18():269-278. PubMed ID: 31201995 [TBL] [Abstract][Full Text] [Related]
14. Genodiversity of resistant Pseudomonas aeruginosa isolates in relation to antimicrobial usage density and resistance rates in intensive care units. Jonas D; Meyer E; Schwab F; Grundmann H Infect Control Hosp Epidemiol; 2008 Apr; 29(4):350-7. PubMed ID: 18269329 [TBL] [Abstract][Full Text] [Related]
15. Antibiotic consumption and resistance: data from Europe and Germany. Meyer E; Gastmeier P; Deja M; Schwab F Int J Med Microbiol; 2013 Aug; 303(6-7):388-95. PubMed ID: 23727396 [TBL] [Abstract][Full Text] [Related]
16. [Sensitivity to antibiotics of bacteria from nosocomial infections. Evolution in resuscitation services of military hospitals]. Garrabé E; Cavallo JD; Brisou P; Chapalain JC; Coué JC; Courrier P; Granic G; Hervé V; Koeck JL; Morillon M; Claude JD; Rouby Y; Teyssou R Presse Med; 2000 Sep; 29(27):1497-503. PubMed ID: 11045115 [TBL] [Abstract][Full Text] [Related]
17. [Surveillance of antibiotic use and bacterial resistance in intensive care units]. Meyer E; Schwab F; Schroeren-Boersch B; Gastmeier P Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Aug; 51(8):926-35. PubMed ID: 18787871 [TBL] [Abstract][Full Text] [Related]
18. Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units. Loeffler JM; Garbino J; Lew D; Harbarth S; Rohner P Scand J Infect Dis; 2003; 35(11-12):843-50. PubMed ID: 14723360 [TBL] [Abstract][Full Text] [Related]
19. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit. Abbara S; Pitsch A; Jochmans S; Hodjat K; Cherrier P; Monchi M; Vinsonneau C; Diamantis S Int J Antimicrob Agents; 2019 Apr; 53(4):416-422. PubMed ID: 30537533 [TBL] [Abstract][Full Text] [Related]
20. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy. Ramsamy Y; Muckart DJ; Han KS S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]